ArticleOncotarget2017

Glibenclamide, a diabetic drug, prevents acute radiation induced liver injury of mice via up-regulating intracellular ROS and subsequently activating Akt-NF-κB pathway.

Hu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.